Allergic Rhinitis Market Forecast Suggests CAGR Acceleration Amid Growing Patient Awareness

The global allergic rhinitis market is on track for significant expansion over the coming years, driven by rising allergy prevalence, increasing environmental pollution, and greater awareness of advanced treatment options. According to the latest industry assessment, the global allergic rhinitis market size is estimated to be valued at US$16.1 billion in 2025 and is projected to reach US$21.5 billion by 2032, reflecting a compound annual growth rate (CAGR) of 4.3% during the forecast period from 2025 to 2032. The market has demonstrated consistent growth over the past few years, supported by robust investments in biotechnology, a surge in research on immunotherapy, and a strong pipeline of biologic drugs addressing chronic and severe allergic conditions.